Transcription factor AP-2 beta (TFAP2B)

Transcription factor AP-2 beta (TFAP2B) is a sequence-specific DNA-binding protein and member of the AP-2 family of transcription factors[1][2][3][4]. These proteins function as both transcriptional activators and repressors, forming homo- or hetero-dimers to regulate genes important for embryonic development, including the formation of neural crest cell derivatives, face, limbs, and other organs[1][2][3][4]. TFAP2B binds to a consensus DNA sequence (GCC(N3)GGC) and modulates key biological processes such as cell proliferation, apoptosis, and terminal differentiation[1][3][4][5]. Mutations in the TFAP2B gene disrupt its function and cause disorders such as autosomal dominant Char syndrome, and are implicated as biomarkers in certain congenital heart diseases[3][4]. The structural integrity and dimerization of TFAP2B are essential for its normal DNA binding and transcriptional regulatory roles[1][5]. TFAP2B and other AP-2 family proteins are also emerging as biomarkers and possible therapeutic targets in cancer and other diseases due to their roles in gene regulation and development[1].

Other names

AP2-betaAP2-BAP-2betaActivating enhancer-binding protein 2-betaAP-2BPDA2Transcription factor AP-2-betaactivating enhancer binding protein 2 beta